Bristol Myers Squibb BMY
NYSE BMY
$61.53 -1.47 (-2.33%)
As of: Oct 23, 2026 · 3:59 PM EDT

Bristol Myers Squibb (BMY) Asset Writedowns and Impairment (2010 - 2026)

Updated

Bristol Myers Squibb (BMY) posted Asset Writedowns and Impairment of $422 million for Q2 2026, up 34.8% from $313 million a year earlier and up 2.4% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Asset Writedowns and Impairment at Bristol Myers Squibb was $1.61 billion, down 33.0% year-over-year; for FY2025, it came in at $1.1 billion, down 62.9% from FY2024.

  • Annual Asset Writedowns and Impairment shows a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
  • In prior years, Bristol Myers Squibb's Asset Writedowns and Impairment was $2.96 billion in FY2024, $255 million in FY2023 (+42.5%), $179 million in FY2022 (-85.2%) and $1.21 billion in FY2021 (+0.3%).
  • Quarterly Asset Writedowns and Impairment has run from a low of $1 million in Q1 2024 to a high of $1.95 billion in Q4 2024 over five years.
  • On a year-over-year basis, Asset Writedowns and Impairment increased in three of the last six quarters, with growth averaging 54.9%.
  • The strongest year-over-year quarter for Asset Writedowns and Impairment in the past five years was Q1 2025, with growth of 400.0%; the weakest was Q4 2021, with a decline of 98.6%.
  • According to Business Quant data, Asset Writedowns and Impairment for the three prior quarters was $412 million (Q1 2026), $584 million (Q4 2025) and $196 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Bristol Myers Squibb 125.99 Bn 77.26 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 422.00 Mn
Mar 31, 2026 412.00 Mn
Dec 31, 2025 584.00 Mn
Sep 30, 2025 196.00 Mn
Jun 30, 2025 313.00 Mn
Mar 31, 2025 5.00 Mn
Dec 31, 2024 1.95 Bn
Sep 30, 2024 139.00 Mn
Jun 30, 2024 870.00 Mn
Mar 31, 2024 1.00 Mn
Dec 31, 2023 29.00 Mn
Sep 30, 2023 159.00 Mn
Jun 30, 2023 47.00 Mn
Mar 31, 2023 20.00 Mn
Dec 31, 2022 35.00 Mn
Sep 30, 2022 61.00 Mn
Jun 30, 2022 42.00 Mn
Mar 31, 2022 41.00 Mn
Dec 31, 2021 15.00 Mn
Sep 30, 2021 613.00 Mn
API Access

Bristol Myers Squibb Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BMY&period=max&api_key=YOUR_API_KEY